Destination market
UK Medical Tourism Market Outlook 2026
UK outbound medical tourism reached an estimated USD 1.95 billion in 2025, driven by NHS elective waitlist pressure (>7 million backlog) and double-digit private-rate inflation. China is now in the top-5 destination set for elective surgery and dental.
Market size, 2021–2030
United Kingdom (England, Scotland, Wales, Northern Ireland) — outbound elective medical travel.
| Year | Market size (USD) | Status |
|---|---|---|
| 2021 | USD 980 million | Historical |
| 2022 | USD 1.21 billion | Historical |
| 2023 | USD 1.48 billion | Historical |
| 2024 | USD 1.72 billion | Historical |
| 2025 | USD 1.95 billion | Latest actual |
| 2026 | USD 2.15 billion | Forecast |
| 2030 | USD 3.12 billion | Forecast |
Demand drivers
- NHS elective waitlist: 7.4 million pathways on the waitlist as of Q4 2025 (NHS England).
- Private rate inflation: UK private orthopedic and bariatric rates rose 12–18% in 2023–2024.
- Strong £/$ purchasing power for treatment in China, Thailand, India, Turkey.
- Returning-resident insurance schemes covering some outbound elective.
Supply-side landscape
- Top outbound destinations by UK patient volume: Turkey (dental, hair, bariatric), Hungary (dental), India (cardiac, orthopedic), China (oncology, orthopedic, IVF), Thailand (orthopedic, cosmetic).
- China share growing fastest from a low base — driven by tier-1 Class A centres offering UK-comparable clinical quality at 40–60% of UK private rates.
- Top UK-patient Chinese destinations: Ruijin Shanghai, PUMCH Beijing, HKU-Shenzhen.
Risks & headwinds
- Visa logistics: UK passport holders need M-visa, 5–10 day processing in London.
- Post-discharge follow-up coordination across jurisdictions is a known friction.
- GMC vs Chinese specialist credentialing — patients should confirm operating-surgeon volume and case mix.
Notable providers
Ruijin Hospital VIP International
Multi-disciplinary destination for UK outbound complex cases.
Class APUMCH International
Rare disease and internal medicine second opinions for UK patients.
Class AHKU-Shenzhen Hospital
English-first international department; strong orthopedic and reproductive medicine.
Class AShanghai Sixth People's Hospital
Orthopedic and microsurgery for UK patients facing NHS waitlists.
Related on this site
Specialty hubFull specialty pillar page
Frequently asked
- How big is the UK medical tourism market?
- USD 1.95 billion in 2025, forecast to USD 3.12 billion by 2030 (9.8% CAGR). The primary driver is the 7.4 million-pathway NHS elective waitlist combined with double-digit UK private-rate inflation.
- Where do UK patients travel for treatment?
- Turkey, Hungary, India, China and Thailand are the top-5 outbound destinations by UK patient volume. China is growing fastest from a low base — UK patients access Class A teaching hospitals at 40–60% of UK private rates.
- Is treatment in China safe for UK patients?
- At Class A international departments in Beijing, Shanghai, Guangzhou, Shenzhen and Chengdu, clinical outcomes are comparable to UK private hospitals for elective orthopedic, bariatric, IVF and oncology care, with English-speaking coordination throughout the pathway.
Sources
- NHS England Referral to Treatment statistics Q4 2025
- UK Office for National Statistics International Passenger Survey 2024
- LaingBuisson UK Healthcare Market Review 2025
- Partner-network 2026 UK outbound quote data
Last reviewed: 2026-05-12.
Going beyond the report
For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.